Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 303

1.

Renal function and effectiveness of angiotensin-converting enzyme inhibitor therapy in patients with chronic stable coronary disease in the Prevention of Events with ACE inhibition (PEACE) trial.

Solomon SD, Rice MM, A Jablonski K, Jose P, Domanski M, Sabatine M, Gersh BJ, Rouleau J, Pfeffer MA, Braunwald E; Prevention of Events with ACE inhibition (PEACE) Investigators.

Circulation. 2006 Jul 4;114(1):26-31. Epub 2006 Jun 26.

PMID:
16801465
[PubMed - indexed for MEDLINE]
Free Article
2.

The cardioprotective effects of the angiotensin-converting enzyme inhibitor perindopril in patients with stable coronary artery disease are not modified by mild to moderate renal insufficiency: insights from the EUROPA trial.

Brugts JJ, Boersma E, Chonchol M, Deckers JW, Bertrand M, Remme WJ, Ferrari R, Fox K, Simoons ML; EUROPA Investigators.

J Am Coll Cardiol. 2007 Nov 27;50(22):2148-55. Epub 2007 Nov 13.

PMID:
18036453
[PubMed - indexed for MEDLINE]
Free Article
3.

Influence of albuminuria on cardiovascular risk in patients with stable coronary artery disease.

Solomon SD, Lin J, Solomon CG, Jablonski KA, Rice MM, Steffes M, Domanski M, Hsia J, Gersh BJ, Arnold JM, Rouleau J, Braunwald E, Pfeffer MA; Prevention of Events With ACE Inhibition (PEACE) Investigators.

Circulation. 2007 Dec 4;116(23):2687-93. Epub 2007 Nov 19.

PMID:
18025537
[PubMed - indexed for MEDLINE]
Free Article
4.

Prognostic value of B-Type natriuretic peptides in patients with stable coronary artery disease: the PEACE Trial.

Omland T, Sabatine MS, Jablonski KA, Rice MM, Hsia J, Wergeland R, Landaas S, Rouleau JL, Domanski MJ, Hall C, Pfeffer MA, Braunwald E; PEACE Investigators.

J Am Coll Cardiol. 2007 Jul 17;50(3):205-14. Epub 2007 Jun 29.

PMID:
17631211
[PubMed - indexed for MEDLINE]
Free Article
5.

Angiotensin-converting-enzyme inhibitors in stable vascular disease without left ventricular systolic dysfunction or heart failure: a combined analysis of three trials.

Dagenais GR, Pogue J, Fox K, Simoons ML, Yusuf S.

Lancet. 2006 Aug 12;368(9535):581-8. Review.

PMID:
16905022
[PubMed - indexed for MEDLINE]
6.

Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.

Anand IS, Bishu K, Rector TS, Ishani A, Kuskowski MA, Cohn JN.

Circulation. 2009 Oct 20;120(16):1577-84. doi: 10.1161/CIRCULATIONAHA.109.853648. Epub 2009 Oct 5.

PMID:
19805651
[PubMed - indexed for MEDLINE]
Free Article
7.

Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?

Weir MR.

Clin Ther. 2007 Sep;29(9):1803-24. Review.

PMID:
18035185
[PubMed - indexed for MEDLINE]
8.

ACE inhibition in secondary prevention: are the results controversial?

Friedrich EB, Teo KK, Böhm M.

Clin Res Cardiol. 2006 Feb;95(2):61-7. Epub 2006 Jan 16.

PMID:
16598512
[PubMed - indexed for MEDLINE]
9.

Angiotensin-converting-enzyme inhibition in stable coronary artery disease.

Braunwald E, Domanski MJ, Fowler SE, Geller NL, Gersh BJ, Hsia J, Pfeffer MA, Rice MM, Rosenberg YD, Rouleau JL; PEACE Trial Investigators.

N Engl J Med. 2004 Nov 11;351(20):2058-68. Epub 2004 Nov 7.

PMID:
15531767
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Trandolapril. An update of its pharmacology and therapeutic use in cardiovascular disorders.

Peters DC, Noble S, Plosker GL.

Drugs. 1998 Nov;56(5):871-93. Review.

PMID:
9829159
[PubMed - indexed for MEDLINE]
11.

Chronic kidney disease, cardiovascular risk, and response to angiotensin-converting enzyme inhibition after myocardial infarction: the Survival And Ventricular Enlargement (SAVE) study.

Tokmakova MP, Skali H, Kenchaiah S, Braunwald E, Rouleau JL, Packer M, Chertow GM, Moyé LA, Pfeffer MA, Solomon SD.

Circulation. 2004 Dec 14;110(24):3667-73. Epub 2004 Nov 29.

PMID:
15569840
[PubMed - indexed for MEDLINE]
Free Article
12.

Angiotensin-converting enzyme inhibition after myocardial infarction: the Trandolapril Cardiac Evaluation Study.

Torp-Pedersen C, Køber L, Carlsen J.

Am Heart J. 1996 Jul;132(1 Pt 2 Su):235-43.

PMID:
8677862
[PubMed - indexed for MEDLINE]
13.

New considerations relating to class effect with angiotensin-converting enzyme inhibitors--the PEACE study.

Sica DA.

J Clin Hypertens (Greenwich). 2005 Mar;7(3):188-93.

PMID:
15785163
[PubMed - indexed for MEDLINE]
14.

Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease.

Sabatine MS, Morrow DA, Jablonski KA, Rice MM, Warnica JW, Domanski MJ, Hsia J, Gersh BJ, Rifai N, Ridker PM, Pfeffer MA, Braunwald E; PEACE Investigators.

Circulation. 2007 Mar 27;115(12):1528-36. Epub 2007 Mar 19.

PMID:
17372173
[PubMed - indexed for MEDLINE]
Free Article
15.

A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group.

Køber L, Torp-Pedersen C, Carlsen JE, Bagger H, Eliasen P, Lyngborg K, Videbaek J, Cole DS, Auclert L, Pauly NC.

N Engl J Med. 1995 Dec 21;333(25):1670-6.

PMID:
7477219
[PubMed - indexed for MEDLINE]
Free Article
16.

Valsartan cardio-renal protection in patients undergoing coronary angiography complicated with chronic renal insufficiency (VAL-CARP) trial: rationale and design.

Ikeda N, Nishimura S, Kyo S, Komiyama N, Matsumoto K, Inoue T, Suzuki H.

Circ J. 2006 May;70(5):548-52.

PMID:
16636488
[PubMed - indexed for MEDLINE]
Free Article
17.

Glomerular filtration rate, cardiorenal end points, and all-cause mortality in type 2 diabetic patients.

So WY, Kong AP, Ma RC, Ozaki R, Szeto CC, Chan NN, Ng V, Ho CS, Lam CW, Chow CC, Cockram CS, Chan JC, Tong PC.

Diabetes Care. 2006 Sep;29(9):2046-52.

PMID:
16936151
[PubMed - indexed for MEDLINE]
18.

Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction.

Anavekar NS, McMurray JJ, Velazquez EJ, Solomon SD, Kober L, Rouleau JL, White HD, Nordlander R, Maggioni A, Dickstein K, Zelenkofske S, Leimberger JD, Califf RM, Pfeffer MA.

N Engl J Med. 2004 Sep 23;351(13):1285-95.

PMID:
15385655
[PubMed - indexed for MEDLINE]
Free Article
19.

Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure and chronic kidney disease.

Berger AK, Duval S, Manske C, Vazquez G, Barber C, Miller L, Luepker RV.

Am Heart J. 2007 Jun;153(6):1064-73.

PMID:
17540211
[PubMed - indexed for MEDLINE]
20.

The landscape after PEACE: do all ACE inhibitors act in an identical way?

Grajek S.

Curr Med Res Opin. 2006 Feb;22(2):265-74.

PMID:
16466598
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk